Progress in Cardiovascular Diseases
Volume 49, Issue 2 , Pages 59-75 , September 2006

Sodium Intake and Hypertension

  • Heikki Karppanen

      Affiliations

    • Corresponding Author InformationAddress reprint request to Heikki Karppanen, MD, PhD, Institute of Biomedicine, Pharmacology Biomedicum, University of Helsinki, PO Box 63, FIN-00014 Helsinki, Finland.
    • ,
  • Eero Mervaala

References 

  1. WHO . Global burden of noncommunicable diseases. http://www.paho.org/English/AD/DPC/NC/World-NCD-burden.ppt2006;
  2. The World Health Organization: diet, nutrition and the prevention of chronic diseases. Technical Report Series 916, 2003
  3. Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296–308
  4. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  5. Khan NA, McAlister FA, Lewanczuk RZ, et al. Canadian Hypertension Education Program: the 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II. Therapy. Can. J. Cardiol. 2005;21:657–672
  6. Godlee F. The food industry fights for salt. Br. Med. J. 1996;312:1239–1240
  7. Salt Institute . Public statements. http://www.saltinstitute.org/advocate.html2006;
  8. European Salt Producers' Association . Press releases. http://www.eu-salt.com/press.htm2006;
  9. Salt Institute . U.S. salt sales. http://www.saltinstitute.org/33.html2006;
  10. Gregg EW, Cheng YJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293:1868–1874
  11. Briefel RR, Johnson CL. Secular trends in dietary intake in the United States. Annu. Rev. Nutr. 2004;24:401–431
  12. Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N. Engl. J. Med. 1985;312:283–289
  13. Eaton SB, Eaton SB. Paleolithic vs. modern diets—selected pathophysiological implications. Eur. J. Nutr. 2000;39:67–70
  14. Karppanen H, Karppanen P, Mervaala E. Why and how to implement sodium, potassium, calcium, and magnesium changes in food items and diets?. J. Hum. Hypertens. 2005;19:S10–S19
  15. Meneton P, Jeunemaitre X, de Wardener HE, et al. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol. Rev. 2005;85:679–715
  16. Eaton SB, Eaton SB, Konner MJ. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur. J. Clin. Nutr. 1997;51:207–216
  17. Laragh JH, Baer L, Brunner HR, et al. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am. J. Med. 1972;52:633–652
  18. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br. Med. J. 1988;298:319–328
  19. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I—Analysis of observational data among populations. Br. Med. J. 1991;302:811–815
  20. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 1997;336:1117–1124
  21. Cohen HW, Hailpern SM, Fang J, et al. Sodium intake and mortality in the NHANES II follow-up study. Am. J. Med. 2006;119:275.e7–275.e14
  22. E. Mervaala, A potassium-, magnesium-, and l-lysine–enriched mineral salt. Cardiovascular and renal effects and interactions with antihypertensive drugs in the rat. Academic Dissertation, University of Helsinki. ISBN 952-90-7197-3. Hakapaino Oy, Helsinki 1995.
  23. Guyton AC. Blood pressure control—special role of the kidneys and body fluids. Science. 1991;252:813–1816
  24. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545–556
  25. Hall JE, Brands MW, Dixon WN, et al. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension. 1993;22:292–299
  26. El-Atat F, McFarlane SI, Sowers JR. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr. Hypertens. Rep. 2004;6:215–223
  27. Akita S, Sacks FM, Svetkey LP, et al. DASH—Sodium Trial Collaborative Research Group Effect of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship. Hypertension. 2003;42:8–13
  28. In:  Rastas M,  Seppänen R,  Knuts L-R, et al. editor. Nutrient composition of foods. Helsinki, Finland: Publications of the Social Insurance Institution; 1993;
  29. U.S. Department of Health and Human Services , U.S. Department of Agriculture . Dietary Guidelines for Americans. http://www.healthierus.gov/dietaryguidelines2005;
  30. Sacks FM, Svetkey LP, Vollmer WM, et al. DASH Collaborative Research Group Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N. Engl. J. Med. 2001;334:3–10
  31. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J. Hum. Hypertens. 2002;16:761–770
  32. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomized trials. J. Hum. Hypertens. 2003;17:471–480
  33. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst. Rev. 2004;CD004937
  34. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997;27:1624–1632
  35. Vaskonen T. Dietary minerals and modification of cardiovascular risk factors. J. Nutr. Biochem. 2003;14:492–506
  36. Griffith LE, Guyatt GH, Cook RJ, et al. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated meta-analysis of randomized controlled trials. Am. J. Hypertens. 1999;1:84–92
  37. Jee SH, Miller ER, Guallar E, et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am. J. Hypertens. 2002;15:691–696
  38. Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension updated: relationship to its action on cardiac, vascular smooth muscle, and endothelial cells. In:  Laragh J,  Brenner BM editor. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven press; 1995;p. 1213–1242
  39. Karppanen H. Minerals and blood pressure. Ann. Med. 1991;2:299–305
  40. Statistics on cardiovascular diseases. Finland: National Public Health Institute; 2003;
  41. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br. Med. J. 1994;309:23–27
  42. Vartiainen E, Sarti C, Tuomilehto J, et al. Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?. Br. Med. J. 1995;310:901–904
  43. Karppanen H, Mervaala E. Adherence to and population impact of non-pharmacological and pharmacological antihypertensive therapy. J. Hum. Hypertens. 1996;10(Suppl. 1):S57–S61
  44. Laatikainen T, Pietinen P, Valsta L, et al. Sodium excretion in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population. Eur. J. Clin. Nutr. 2006;60:965–970
  45. T. Laatikainen, H. Tapanainen, G. Alftan, et al: FINRISKI 2002. Publications of the National Public Health Institute B7/2003
  46. National Research and Development Centre for Welfare and Health . Statistics. http://www.stakes.fi/FI/Tilastot/Aiheittain/Paihteet/alkoholijuomienkulutus2005.htm
  47. Mervaala EMA, Himberg J-J, Laakso J, et al. Beneficial effects of a potassium- and magnesium-enriched salt alternative. Hypertension. 1992;19:535–540
  48. Jula A, Karanko H. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation. 1994;89:1023–1031
  49. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation. 1994;89:1041–1050
  50. Reinivuo H, Valsta LM, Laatikainen T, et al. Sodium in the Finnish diet: II. Trends in dietary sodium intake and comparison between intake and 24-h excretion of sodium. Eur J Clin Nutr. 1998;12:1–92
  51. Ministry of Social Affairs and Health . Consensus statement. Action plan for promoting Finnish heart health. Publications. 1998;12:1–92
  52. Karppanen H. An antihypertensive salt: crucial role of Mildred Seelig in its development. J. Am. Coll. Nutr. 1994;13:493–495
  53. USDA . Food consumption data. http://www.ers.usda.gov/Data/FoodConsumption/spreadsheets/beverage.xls#Total!A12006;
  54. U.S. Census Bureau . Statistical abstract of the United States. http://www.census.gov/prod/2004pubs/03statab/pop.pdf2003;
  55. Whelton PK, He J, Appel LJ, et al. for the National High Blood Pressure Education Program Coordinating Committee Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA. 2002;288:1882–1888
  56. National Heart, Lung, and Blood Institute . Obesity education initiative. http://hp2010.nhlbihin.net/oei_ss/PDII/download/ppt/PD2.ppt2006;
  57. Young LR, Nestle M. The contribution of expanding portion sizes to the US obesity epidemic. Am. J. Public Health. 2002;92:246–249
  58. Matthiessen J, Fagt S, Biltoft-Jensen A, et al. Size makes difference. Public Health Nutr. 2003;6:65–72
  59. Pietinen P. Estimating sodium intake from food consumption data. Ann. Nutr. Metab. 1982;26:90–99
  60. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet. 1998;351:781–785
  61. MacGregor GA, de Wardener HE. Salt, diet and health. In: Cambridge, United Kingdom: Cambridge University Press; 1998;p. 194–195
  62. Nielsen SJ, Popkin BM. Changes in beverage intake. Am. J. Prev. Med. 2004;27:205–210
  63. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292:927–934
  64. American Beverage Association . Soft drink facts. http://www.ameribev.org/variety/facts.asp
  65. Jurgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, rennin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst. Rev. 2003;CD004022
  66. Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;357:848–851
  67. CASH: Consensus Action on Salt and Health. http://www.actiononsalt.org.uk/index.htm2006;
  68. Tikkanen MJ, Högström P, Tuomilehto J, et al. Effect of diet based on low-fat foods enriched with nonesterified plant sterols and mineral nutrients on serum cholesterol. Am. J. Cardiol. 2001;88:1157–1162
  69. Karppanen H, Tanskanen A, Tuomilehto J, et al. Safety and effects of potassium- and magnesium-containing low sodium salt mixtures. J. Cardiovasc. Pharmacol. 1984;6(Suppl 1):S236–S243
  70. Geleijnse JM, Witteman JC, Bak AA, et al. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Br. Med. J. 1994;309:436–440
  71. Karppanen H, Vaskonen T, Mervaala E. Novel “MultiBene” food composition lowers serum cholesterol and decreases obesity. In: XIII International symposium on drugs affecting lipid metabolism, Florence. 1998;p. 32
  72. Vaskonen T, Mervaala E, Krogerus L, et al. Supplementation of plant sterols and minerals benefits obese Zucker rats fed an atherogenic diet. J. Nutr. 2002;132:231–237

PII: S0033-0620(06)00083-1

doi: 10.1016/j.pcad.2006.07.001

Progress in Cardiovascular Diseases
Volume 49, Issue 2 , Pages 59-75 , September 2006

Article Tools

* Image Usage & Resolution